tiprankstipranks
Trending News
More News >
Incannex Healthcare Limited Sponsored ADR (IXHL)
NASDAQ:IXHL
US Market

Incannex Healthcare Limited Sponsored ADR (IXHL) Stock Statistics & Valuation Metrics

Compare
75 Followers

Total Valuation

Incannex Healthcare Limited Sponsored ADR has a market cap or net worth of $14.33M. The enterprise value is .
Market Cap$14.33M
Enterprise Value

Share Statistics

Incannex Healthcare Limited Sponsored ADR has 27.55M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding27.55M
Owened by Insiders0.56%
Owened by Instutions1.07%

Financial Efficiency

Incannex Healthcare Limited Sponsored ADR’s return on equity (ROE) is -1.65 and return on invested capital (ROIC) is -259.62%.
Return on Equity (ROE)-164.56%
Return on Assets (ROA)-108.28%
Return on Invested Capital (ROIC)-259.62%
Return on Capital Employed (ROCE)-262.89%
Revenue Per Employee$2,666.667
Profits Per Employee-$1,372,777.778
Employee Count9
Asset Turnover<0.01
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Incannex Healthcare Limited Sponsored ADR is -2.58. Incannex Healthcare Limited Sponsored ADR’s PEG ratio is 0.04.
PE Ratio-2.58
PS Ratio3.97K
PB Ratio4.25
Price to Fair Value4.25
Price to FCF-2.96
Price to Operating Cash Flow-3.01
PEG Ratio0.04

Income Statement

In the last 12 months, Incannex Healthcare Limited Sponsored ADR had revenue of $24.00K and earned -$12.36M in profits. Earnings per share was -$0.71.
Revenue$24.00K
Gross Profit$24.00K
Operating Income-$14.75M
Pretax Income-$12.32M
Net Income-$12.36M
EBITDA-11.99M
Earnings Per Share (EPS)-0.71

Cash Flow

In the last 12 months, operating cash flow was -$7.87M and capital expenditures -$8.00K, giving a free cash flow of -$7.89M billion.
Operating Cash Flow-$7.87M
Free Cash Flow-$7.89M
Free Cash Flow per Share-$0.29

Dividends & Yields

Incannex Healthcare Limited Sponsored ADR pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-33.81%
Earnings Yield-38.71%

Stock Price Statistics

Beta1.91
52-Week Price Change-83.93%
50-Day Moving Average1.24
200-Day Moving Average1.86
Relative Strength Index (RSI)23.60
Average Volume (3m)54.34K

Important Dates

Incannex Healthcare Limited Sponsored ADR upcoming earnings date is Aug 27, 2025, Before Open.
Last Earnings DateFeb 14, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date

Financial Position

Incannex Healthcare Limited Sponsored ADR as a current ratio of 2.88, with Debt / Equity ratio of 0.03
Current Ratio2.88
Quick Ratio2.88
Debt to Market Cap0.00
Net Debt to EBITDA0.30
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Incannex Healthcare Limited Sponsored ADR has paid $30.00K in taxes.
Income Tax$30.00K
Effective Tax Rate-0.16%

Enterprise Valuation

Incannex Healthcare Limited Sponsored ADR EV to EBITDA ratio is -2.28, with an EV/FCF ratio of -2.62.
EV to Sales3.52K
EV to EBITDA-2.28
EV to Free Cash Flow-2.62
EV to Operating Cash Flow-2.66

Balance Sheet

Incannex Healthcare Limited Sponsored ADR has $2.10M in cash and marketable securities with $4.10M in debt, giving a net cash position of $2.00M billion.
Cash & Marketable Securities$2.10M
Total Debt$4.10M
Net Cash$2.00M
Net Cash Per Share$0.07
Tangible Book Value Per Share$0.69

Margins

Gross margin is 100.00%, with operating margin of -250341.67%, and net profit margin of -153825.00%.
Gross Margin100.00%
Operating Margin-250341.67%
Pretax Margin-153575.00%
Net Profit Margin-153825.00%
EBITDA Margin-154200.00%
EBIT Margin-155058.33%

Analyst Forecast

The average price target for Incannex Healthcare Limited Sponsored ADR is , which is 11.43% higher than the current price. The consensus rating is
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score2
AI Score34
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis